CH416647A - Verfahren zur Herstellung von Piperazinderivaten mit antibiotischer Wirkung - Google Patents

Verfahren zur Herstellung von Piperazinderivaten mit antibiotischer Wirkung

Info

Publication number: CH416647A
Authority: CH; Switzerland
Prior art keywords: tetracycline; solution; piperazine; reaction; production
Prior art date: 1961-01-04

Application number

CH1501561A

Other languages

German (de)

English (en)

Inventor

Gyula Dr Kollar

Lajos Dipl Ing Chem Sipos

Pato Gabor

Original Assignee

Chinoin Gyogyszer Es Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1961-01-04

Filing date

1961-12-27

Publication date

1966-07-15

1961-12-27 Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet

1966-07-15 Publication of CH416647A publication Critical patent/CH416647A/de

Links

238000000034 method Methods 0.000 title claims description 13
238000004519 manufacturing process Methods 0.000 title claims description 6
230000003115 biocidal effect Effects 0.000 title description 7
150000004885 piperazines Chemical class 0.000 title description 3
229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 22
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 18
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 15
150000003839 salts Chemical class 0.000 claims description 11
229960002180 tetracycline Drugs 0.000 claims description 11
239000004098 Tetracycline Substances 0.000 claims description 10
235000019364 tetracycline Nutrition 0.000 claims description 10
229930101283 tetracycline Natural products 0.000 claims description 10
150000003522 tetracyclines Chemical class 0.000 claims description 9
238000006243 chemical reaction Methods 0.000 claims description 7
150000007524 organic acids Chemical class 0.000 claims description 4
239000000460 chlorine Substances 0.000 claims description 3
229910052801 chlorine Inorganic materials 0.000 claims description 3
235000005985 organic acids Nutrition 0.000 claims description 3
239000002904 solvent Substances 0.000 claims description 3
-1 chlorine tetracycline Chemical class 0.000 claims description 2
125000001309 chloro group Chemical group Cl* 0.000 claims description 2
239000001257 hydrogen Chemical group 0.000 claims description 2
229910052739 hydrogen Chemical group 0.000 claims description 2
230000001476 alcoholic effect Effects 0.000 claims 1
125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
239000000243 solution Substances 0.000 description 22
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
239000000047 product Substances 0.000 description 14
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
150000001875 compounds Chemical class 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
239000011541 reaction mixture Substances 0.000 description 9
229960005141 piperazine Drugs 0.000 description 8
238000000354 decomposition reaction Methods 0.000 description 6
239000004099 Chlortetracycline Chemical group 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Chemical group C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 5
CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical group C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 5
229960004475 chlortetracycline Drugs 0.000 description 5
235000019365 chlortetracycline Nutrition 0.000 description 5
238000002347 injection Methods 0.000 description 5
239000007924 injection Substances 0.000 description 5
239000002244 precipitate Substances 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
230000004071 biological effect Effects 0.000 description 4
238000002844 melting Methods 0.000 description 4
230000008018 melting Effects 0.000 description 4
239000000203 mixture Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 3
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
239000001630 malic acid Substances 0.000 description 3
235000011090 malic acid Nutrition 0.000 description 3
229960003506 piperazine hexahydrate Drugs 0.000 description 3
AVRVZRUEXIEGMP-UHFFFAOYSA-N piperazine;hexahydrate Chemical compound O.O.O.O.O.O.C1CNCCN1 AVRVZRUEXIEGMP-UHFFFAOYSA-N 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000003756 stirring Methods 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000037396 body weight Effects 0.000 description 2
239000003610 charcoal Substances 0.000 description 2
238000009833 condensation Methods 0.000 description 2
230000005494 condensation Effects 0.000 description 2
239000008098 formaldehyde solution Substances 0.000 description 2
239000012458 free base Substances 0.000 description 2
229940093915 gynecological organic acid Drugs 0.000 description 2
239000007927 intramuscular injection Substances 0.000 description 2
238000010255 intramuscular injection Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
239000000843 powder Substances 0.000 description 2
239000007858 starting material Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
ACTFDRRTVUIDFZ-ZZEGOUJXSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;trihydrate Chemical compound O.O.O.C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O ACTFDRRTVUIDFZ-ZZEGOUJXSA-N 0.000 description 1
QYAPHLRPFNSDNH-MRFRVZCGSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-MRFRVZCGSA-N 0.000 description 1
RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
239000004100 Oxytetracycline Substances 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
239000001361 adipic acid Substances 0.000 description 1
235000011037 adipic acid Nutrition 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000003973 alkyl amines Chemical class 0.000 description 1
JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
230000036765 blood level Effects 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000005518 carboxamido group Chemical group 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
238000001816 cooling Methods 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000012259 ether extract Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
150000002391 heterocyclic compounds Chemical class 0.000 description 1
150000004687 hexahydrates Chemical class 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
229940011051 isopropyl acetate Drugs 0.000 description 1
GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
239000000155 melt Substances 0.000 description 1
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
229960000625 oxytetracycline Drugs 0.000 description 1
235000019366 oxytetracycline Nutrition 0.000 description 1
238000004816 paper chromatography Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
229960002423 tetracycline trihydrate Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
150000003628 tricarboxylic acids Chemical class 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

CH1501561A 1961-01-04 1961-12-27 Verfahren zur Herstellung von Piperazinderivaten mit antibiotischer Wirkung CH416647A (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HUCI000362		1961-01-04

Publications (1)

Publication Number	Publication Date
CH416647A true CH416647A (de)	1966-07-15

Family

ID=10994297

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH1501561A CH416647A (de)	1961-01-04	1961-12-27	Verfahren zur Herstellung von Piperazinderivaten mit antibiotischer Wirkung

Country Status (4)

Country	Link
CH (1)	CH416647A (fr)
DE (1)	DE1193950B (fr)
FR (1)	FR1880M (fr)
GB (1)	GB950536A (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1044806B (de) *	1956-10-03	1958-11-27	Hoechst Ag	Verfahren zur Herstellung von wasserloeslichen Derivaten der Tetracycline

1961
- 1961-12-27 CH CH1501561A patent/CH416647A/de unknown
- 1961-12-29 DE DEC25860A patent/DE1193950B/de active Pending
- 1961-12-29 GB GB46678/61A patent/GB950536A/en not_active Expired
1962
- 1962-01-03 FR FR883776A patent/FR1880M/fr active Active

Also Published As

Publication number	Publication date
GB950536A (en)	1964-02-26
DE1193950B (de)	1965-06-03
FR1880M (fr)	1963-07-01

Publication	Publication Date	Title
DE1296626B (de)	1969-06-04	Verfahren zur Herstellung von 11a-Fluortetracyclinen
DE1593579B1 (de)	1972-02-03	Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung
DE2829580C2 (de)	1985-10-24	2-Formylchinoxalin-1,4-dioxid-cyanoacetylhydrazon, Verfahren zu seiner Herstellung und Zusammensetzungen mit dieser Verbindung
DE2641388C3 (de)	1981-02-05	3',4'-Didesoxykanamycin B-N-methansulfonsäuren und deren Alkalimetallsalze sowie diese Verbindungen enthaltende pharmazeutische Präparate
DE2903891A1 (de)	1979-08-23	Optisch aktive benzamide, verfahren zu deren herstellung und deren anwendung
DE1300955B (de)	1969-08-14	p-Chlorphenoxyessigsaeure-(beta-dimethylaminoaethyl)-ester, dessen Hydrochlorid und Verfahren zu deren Herstellung
DE1770408A1 (de)	1971-10-21	Links-1-n-Butyl-2',6'-Pipecoloxylidid und Verfahren zu seiner Herstellung
CH416647A (de)	1966-07-15	Verfahren zur Herstellung von Piperazinderivaten mit antibiotischer Wirkung
AT226713B (de)	1963-04-10	Verfahren zur Herstellung von neuen Piperazinderivaten
DE1470013A1 (de)	1970-03-19	Verfahren zur Herstellung von Tetracyclin-Derivaten
DE2230003A1 (de)	1973-01-18	Neue nitrosoharnstoffderivate
DE1952800C3 (de)	1974-04-18	3,6-Dimethyl-l,2,3,4,4a,9a-hexahydro-gamma-carbolin-dihydrochlorid
DE2628042C3 (de)	1979-11-29	3-Amino-tricyclo [5.3.1.0.38I -undecan, dessen Säureadditionssalze und Verfahren zur Herstellung dieser Verbindungen
AT267065B (de)	1968-12-10	Verfahren zur Herstellung neuer Tetrazyklinderivate
AT216145B (de)	1961-07-10	Verfahren zur Herstellung von neuen therapeutisch wertvollen Verbindungen
AT220288B (de)	1962-03-12	Verfahren zur Herstellung von neuen therapeutisch wirksamen Estern des Erythromycins
DE2420152C3 (de)	1978-09-07	Hochmolekulare Derivate des ß-Diäthylaminoäthylesters der p-Aminobenzoesäure mit Carboxyformal des Polyvinylalkohole
DE666066C (de)	1938-10-08	Verfahren zur Herstellung von Dialkylaminoalkylamiden hochmolekularer Fettsaeuren
AT221513B (de)	1962-06-12	Verfahren zur Herstellung von neuen basischen Estern und ihren Salzen
DE1470357C (de)	1971-07-01	1 (3 Dimethylammopropyl) 4 myristoyl amidopiperidin, dessen Saureadditionssalze und Verfahren zu ihrer Herstellung
DE822993C (de)	1951-11-29	Verfahren zur Herstellung asymmetrischer Arsenobenzolverbindungen
AT247519B (de)	1966-06-10	Verfahren zur Herstellung neuer Additionsverbindungen von Antibiotika
DE206057C (fr)
DE1923247C2 (de)	1971-07-08	3-trans-Dimethylamino-4-phenyl-4-trans-aethoxycarbonylcyclohexen(1),dessen D- bzw. L-Tartrat,D- bzw. L-O,O-Dibenzoyltartrat bzw. Hydrochlorid
AT265530B (de)	1968-10-10	Verfahren zur Herstellung von neuen Isochinolinderivaten